IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Anthem Biosciences Ltd.
Issue Open Date 14-Jul-25  
Issue Closing Date 16-Jul-25  
Application Money 100  
Allotment Money  
Price Band 540 - 570  
Minimium Application No. 26  
Issue Size (Shares) 44070682  
Market Lot 1.00  
Objective
(i) to carry out the Offer for Sale of up to [?] Equity Shares of face value of ? 2 each by theSelling Shareholders aggregating up to ? 33,950.00 million; and(ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   9407639   398469578   42.36  
Qualified Institutional Buyers   12543518   2291095976   182.65  
Retail Individual Investors   21951158   123847828   5.64  
Business Description
We are an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization(“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing. We are one ofthe few companies in India wi
more...
Promoter's Holding
Total Share Capital   431747949  
Offered to Public   44070682  
Promoter's Holding (Pre-Issue)   77.23  
Promoter's Holding (Post-Issue)   74.69  
Address
No. 49
F1 & F2
Canara Bank Road
Bommasandra Industrial Area
Phase I
Bommasandra
Bengaluru ,
Karnataka ,
560099
Phone: 080-66724000
Email: investors.abl@anthembio.com
Website: www.anthembio.com
Registrar
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B
Plot 31-32
Gachibowli
Financial District
Nanakramguda
Hyderabad
Listed at
BSE, NSE
Lead Manager
Citigroup Global Markets India Pvt Ltd.
JM Financial Ltd.
JP Morgan India Pvt Ltd
Nomura Financial Advisory & Securities (India) Pvt Ltd.
Promoters
Ajay Bhardwaj
Ganesh Sambasivam
Ishaan Bhardwaj
K Ravindra Chandrappa
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.